Drug Discovery for Overcoming Chronic Kidney Disease (CKD): The Endothelin ETB Receptor / Nitric Oxide System Functions as a Protective Factor in CKD

Journal of Pharmacological Sciences - Japan
doi 10.1254/jphs.08r10fm
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKD

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2009English

Retarding Chronic Kidney Disease (CKD) Progression: A Practical Nutritional Approach for Non-Dialysis CKD

Nephrology @ Point of Care
2016English

Roles of Coagulation Pathway and Factor Xa in Chronic Kidney Disease (CKD)

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2012English

Chronic Kidney Disease (CKD) and Cardiovascular Disease (CVD) in the Elderly

Japanese Journal of Geriatrics
GerontologyGeriatrics
2012English

Rationale and Design of a Multicenter Chronic Kidney Disease (CKD) and At-Risk for CKD Electronic Health Records-Based Registry: CURE-CKD

BMC Nephrology
Nephrology
2019English

Oxidative Stress (OS) in Chronic Kidney Disease (CKD): A Mini Review

Nephrology and Renal Diseases
2018English

The Unfolded Protein Response: A Novel Insight Into Chronic Kidney Disease (CKD)

Nephrology – Open Journal
2017English

Chronic Hepatitis C Increases the Risk of Chronic Kidney Disease (CKD) While Effective HCV Treatment Decreases the Incidence of CKD

Hepatology
MedicineHepatology
2017English

Chronic Kidney Disease: Intensive Blood Pressure Reduction Lowers Mortality in CKD

Nature Reviews Nephrology
Nephrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy